We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$16.1B
AUM Growth
+$1.98B
Cap. Flow
+$1.34B
Cap. Flow %
8.3%
Top 10 Hldgs %
18.52%
Holding
1,899
New
351
Increased
456
Reduced
282
Closed
805

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$260M
2
BABA icon
Alibaba
BABA
+$229M
3
GILD icon
Gilead Sciences
GILD
+$168M
4
BA icon
Boeing
BA
+$151M
5
ABT icon
Abbott
ABT
+$148M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$306M
2
UNH icon
UnitedHealth
UNH
+$244M
3
VMC icon
Vulcan Materials
VMC
+$146M
4
PEP icon
PepsiCo
PEP
+$98.4M
5
ELV icon
Elevance Health
ELV
+$96.5M

Sector Composition

Rank Sector Weight
1 Healthcare 27.6%
2 Technology 15.66%
3 Consumer Discretionary 13.93%
4 Industrials 11.16%
5 Communication Services 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ETSY icon
351
Etsy
ETSY
$7.85B
$5.2M 0.03%
84,801
+70,008
+473% +$4.57M
DFS
352
DELISTED
Discover Financial Services
DFS
$5.18M 0.03%
66,799
+585
+0.9% +$45.3K
NEO icon
353
NeoGenomics
NEO
$2.13B
$5.18M 0.03%
236,238
+27,432
+13% +$602K
FDS icon
354
Factset
FDS
$10.2B
$5.17M 0.03%
18,050
+10,045
+125% +$2.78M
AGIO icon
355
Agios Pharmaceuticals
AGIO
$1.93B
$5.16M 0.03%
+103,391
New +$5.53M
IOVA icon
356
Iovance Biotherapeutics
IOVA
$2.87B
$5.15M 0.03%
210,174
-105,275
-33% -$1.59M
FLIR
357
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
$5.15M 0.03%
95,195
-91,113
-49% -$4.62M
RY icon
358
Royal Bank of Canada
RY
$293B
$5.09M 0.03%
63,900
-52,900
-45% -$4.13M
VRAY
359
DELISTED
ViewRay, Inc.
VRAY
$5.08M 0.03%
577,102
+327,487
+131% +$2.66M
GMED icon
360
Globus Medical
GMED
$11.2B
$5.02M 0.03%
118,715
+59,501
+100% +$2.58M
ELV icon
361
Elevance Health
ELV
$85.5B
$5.01M 0.03%
17,772
-353,403
-95% -$96.5M
KFY icon
362
Korn Ferry
KFY
$4.28B
$5M 0.03%
124,736
+74,353
+148% +$3.38M
LGND icon
363
Ligand Pharmaceuticals
LGND
$6.36B
$4.99M 0.03%
70,000
-43,901
-39% -$3.23M
YUM icon
364
Yum! Brands
YUM
$41.1B
$4.99M 0.03%
45,043
-87,599
-66% -$9.1M
CBRL icon
365
Cracker Barrel
CBRL
$1.29B
$4.98M 0.03%
+29,192
New +$4.78M
TVTY
366
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$4.94M 0.03%
300,176
+72,819
+32% +$1.41M
PFE icon
367
Pfizer
PFE
$153B
$4.92M 0.03%
119,779
-7,713,522
-98% -$306M
PK icon
368
Park Hotels & Resorts
PK
$2.97B
$4.92M 0.03%
+178,528
New +$5.35M
PRAH
369
DELISTED
PRA Health Sciences, Inc.
PRAH
$4.88M 0.03%
49,197
+5,778
+13% +$551K
KBH icon
370
KB Home
KBH
$3.59B
$4.88M 0.03%
189,547
+58,536
+45% +$1.51M
CMA
371
DELISTED
Comerica
CMA
$4.87M 0.03%
67,042
+46,084
+220% +$3.42M
EVH icon
372
Evolent Health
EVH
$447M
$4.87M 0.03%
611,969
+329,666
+117% +$3.9M
BHVN
373
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$4.86M 0.03%
+110,998
New +$6.26M
CP icon
374
Canadian Pacific Kansas City
CP
$80.5B
$4.83M 0.03%
102,250
-455,450
-82% -$20.3M
LX
375
LexinFintech Holdings
LX
$241M
$4.8M 0.03%
430,125
+248,278
+137% +$3.09M
13 14
15
16 17

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q2 2019 Portfolio in Review

As of Q2 2019, Marshall Wace North America held 1,899 positions worth $16.1B, up 14% from $14.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Marshall Wace North America deployed $1.34B of net new capital in Q2 2019, opening 351 new positions and adding to 456 existing holdings. Its largest new stake was Abbott: 1,884,363 shares worth $158M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Pfizer, an estimated $306M trimmed.

  • Marshall Wace North America's largest Q2 2019 buy was Abbott: 1,884,363 shares worth $158M.
  • Marshall Wace North America added most to Meta Platforms (Facebook) in Q2 2019, an estimated $260M increase.
  • Marshall Wace North America's biggest Q2 2019 reduction was Pfizer, cutting an estimated $306M.
  • Marshall Wace North America fully exited UnitedHealth in Q2 2019, selling an estimated $244M.
  • Marshall Wace North America's ten largest holdings make up 19% of its $16.1B portfolio in Q2 2019.
  • Marshall Wace North America opened 351 new positions and closed 805 in Q2 2019.
  • Marshall Wace North America's portfolio value rose 14% quarter-over-quarter to $16.1B.

Based on Marshall Wace North America's 13F filing for Q2 2019, filed 14 Aug 2019.